APA

Brewer N. T., Defrank J. T., Chiu W. K., Ibrahim J. G., Walko C. M., Rubin P., Olajide O. A., Moore S. G., Raab R. E., Carrizosa D. R., Corso S. W., Schwartz G., Peppercorn J. M., McLeod H. L., Carey L. A. & Irvin W. J. (20140508). Patients' understanding of how genotype variation affects benefits of tamoxifen therapy for breast cancer. : Public health genomics.

Chicago

Brewer N T, Defrank J T, Chiu W K, Ibrahim J G, Walko C M, Rubin P, Olajide O A, Moore S G, Raab R E, Carrizosa D R, Corso S W, Schwartz G, Peppercorn J M, McLeod H L, Carey L A and Irvin W J. 20140508. Patients' understanding of how genotype variation affects benefits of tamoxifen therapy for breast cancer. : Public health genomics.

Harvard

Brewer N. T., Defrank J. T., Chiu W. K., Ibrahim J. G., Walko C. M., Rubin P., Olajide O. A., Moore S. G., Raab R. E., Carrizosa D. R., Corso S. W., Schwartz G., Peppercorn J. M., McLeod H. L., Carey L. A. and Irvin W. J. (20140508). Patients' understanding of how genotype variation affects benefits of tamoxifen therapy for breast cancer. : Public health genomics.

MLA

Brewer N T, Defrank J T, Chiu W K, Ibrahim J G, Walko C M, Rubin P, Olajide O A, Moore S G, Raab R E, Carrizosa D R, Corso S W, Schwartz G, Peppercorn J M, McLeod H L, Carey L A and Irvin W J. Patients' understanding of how genotype variation affects benefits of tamoxifen therapy for breast cancer. : Public health genomics. 20140508.